Psychological Resilience and Quality of Life in Mycosis Fungoides Patients: A BIO-MUSE Study
DOI:
https://doi.org/10.2340/actadv.v106.adv-2025-0211Keywords:
cutaneous T cell Lymphoma, dermatology, mycosis fungoides, psychological resilience, quality of lifeAbstract
Cutaneous T-cell lymphoma is a chronic disease with a highly heterogeneous and unpre-dictable clinical course, and the impact on psychological resilience is still unknown. The primary aim was to investigate psychological resilience in cutaneous T-cell lymphoma patients over time and to relate it to dermatology-related quality of life (QoL) metrics. Psychological investigations were evaluated in 45 patients with mycosis fungoides included in the BIO-MUSE study. Psychological resilience was assessed using the Connor–Davidson Resilience Scale (CD-RISC), and dermatology-associated QoL was assessed with the Dermatology Life Quality Index (DLQI) and numeric rating scales for itch and sleep disorders. The resilience of the mycosis fungoides patients was further compared to a Swedish general population cohort comprising more than 2,500 individuals. This study demonstrates that mycosis fungoides patients in the BIO-MUSE cohort, where 39 of 45 cases had early-stage disease, exhibit a high and stable resilience over 1 year of the disease. The CD-RISC score is higher than in a Swedish general population cohort and in a subgroup of that cohort with psoriasis or eczema. Furthermore, the DLQI was consistently low, indicating a higher QoL in the BIO-MUSE cohort than in published data for similar patient populations.
Downloads
References
Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133: 1703–1714. DOI: https://doi.org/10.1182/blood-2018-11-881268
Kempf W, Zimmermann AK, Mitteldorf C. Cutaneous lymphomas-An update 2019. Hematol Oncol 2019; 37: 43–47. DOI: https://doi.org/10.1002/hon.2584
Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: Validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010; 28: 4730–4739. DOI: https://doi.org/10.1200/JCO.2009.27.7665
Mourad A, Gniadecki R. Overall survival in mycosis fungoides: A systematic review and meta-analysis. J Invest Dermatol 2020; 140: 495–497. DOI: https://doi.org/10.1016/j.jid.2019.07.712
Brunner PM, Jonak C, Knobler R. Recent advances in understanding and managing cutaneous T-cell lymphomas. F1000Res 2020; 9: 9. DOI: https://doi.org/10.12688/f1000research.21922.1
Brazel D, Larocca C, Shinohara MM. Assessing health-related quality of life in mycosis fungoides and Sézary syndrome: Unmet needs. Cancers (Basel) 2024; 16: 2757. DOI: https://doi.org/10.3390/cancers16152757
Molloy K, Jonak C, Woei-A-Jin FJSH, Guenova E, Busschots AM, Bervoets A, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol 2020; 182: 770–779. DOI: https://doi.org/10.1111/bjd.18089
Damiani G, Tacastacas JD, Wuerz T, Miller L, Fastenau P, Bailey C, et al. Cognition/psychological burden and resilience in cutaneous T-cell lymphoma and psoriasis patients: Real-life data and implications for the treatment. Biomed Res Int 2022; 2022: 8802469. DOI: https://doi.org/10.1155/2022/8802469
Ottevanger R, van Beugen S, Evers AWM, Willemze R, Vermeer MH, Quint KD. Quality of life in patients with mycosis fungoides and Sézary syndrome: A systematic review of the literature. J Eur Acad Dermatol Venereol 2021; 35: 2377–2387. DOI: https://doi.org/10.1111/jdv.17570
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--A simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216. DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Chen CC, Sun XF, Liu ZY, Jiao MR, Wei WH, Hu YL. The relationship between resilience and quality of life in advanced cancer survivors: Multiple mediating effects of social support and spirituality. Front Public Health 2023; 11: 11. DOI: https://doi.org/10.3389/fpubh.2023.1207097
Musich S, Wang SHS, Schaeffer JA, Kraemer S, Wicker E, Yeh CS. The association of increasing resilience with positive health outcomes among older adults. Geriatr Nurs 2022; 44: 97–104. DOI: https://doi.org/10.1016/j.gerinurse.2022.01.007
Connor KM, Davidson JRT. Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety 2003; 18: 76–82. DOI: https://doi.org/10.1002/da.10113
Sharif-Nia H, Sánchez-Teruel D, Sivarajan Froelicher E, Hejazi S, Hosseini L, Khoshnavay Fomani F, et al. Connor-Davidson Resilience Scale: A systematic review psychometrics properties using the COSMIN. Ann Med Surg (Lond) 2024; 86: 2976–2991. DOI: https://doi.org/10.1097/MS9.0000000000001968
Velickovic K, Rahm Hallberg I, Axelsson U, Borrebaeck CAK, Rydén L, Johnsson P, et al. Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden. Health Qual Life Outcomes 2020; 18: 132. DOI: https://doi.org/10.1186/s12955-020-01383-3
Belfrage E, Ek S, Johansson Å, Brauner H, Sonesson A, Drott K. Predictive and prognostic biomarkers in patients with mycosis fungoides and Sézary syndrome (BIO-MUSE): Protocol for a translational study. JMIR Res Protoc 2024; 13: e55723. DOI: https://doi.org/10.2196/55723
Söder KSSF. Region Skåne: BIG3. 2022.
Tillé Y. Sampling algorithms. In: Lovric M, editor. International Encyclopedia of Statistical Science. 2 edn. Vol Berlin Heidelberg: Springer; 2025. DOI: https://doi.org/10.1007/978-3-662-69359-9_545
Folkhälsomyndigheten. Vuxnas bruk av tobaks och nikotinprodukter. 2024.
Dancey CPaR J. Statistics without maths for psychology. 4 edn. Harlow: Pearson Education; 2007.
Team RC. R: A Language and Environment for Statistical Computing. 4.2.2 edn. R Foundation for Statistical Computing; 2022.
Corp I. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp; 2023.
Mohlin Å, Bendahl PO, Hegardt C, Richter C, Hallberg IR, Rydén L. Psychological resilience and health-related quality of life in 418 Swedish women with primary breast cancer: Results from a prospective longitudinal study. Cancers (Basel) 2021; 13: 13. DOI: https://doi.org/10.3390/cancers13092233
Axelsson U, Rydén L, Johnsson P, Edén P, Månsson J, Hallberg IR, et al. A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: Study protocol of the SCAN-B resilience study. BMC Cancer 2018; 18: 789. DOI: https://doi.org/10.1186/s12885-018-4669-y
Veličković K, Borrebaeck CAK, Bendahl PO, Hegardt C, Johnsson P, Richter C, et al. One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life. Front Oncol 2022; 12: 891850. DOI: https://doi.org/10.3389/fonc.2022.891850
Quaglino P, Prince HM, Cowan R, Vermeer M, Papadavid E, Bagot M, et al. Treatment of early-stage mycosis fungoides: Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol 2021; 184: 722–730. DOI: https://doi.org/10.1111/bjd.19252
Shen ZY, Zhang L, Shi SJ, Ruan CH, Dan L, Li CY. The relationship between uncertainty and fear of disease progression among newly diagnosed cancer patients: The mediating role of intolerance of uncertainty. BMC Psychiatry 2024; 24: 24. DOI: https://doi.org/10.1186/s12888-024-06201-4
Nenonen J, Winther AH, Jonsson P, Ivert LU, Brauner H. Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life. Front Oncol 2025; 15: 1524353. DOI: https://doi.org/10.3389/fonc.2025.1524353
Hub D, Drott K, Belfrage E, Sonesson A. Quality of life in a Swedish cohort of patients with mycosis fungoides. Acta Derm Venereol 2026; 106: 0364. DOI: https://doi.org/10.2340/actadv.v106.adv-2026-0364
Jennings T, Duffy R, Gochoco A, Knoblauch K, Shi W, Alpdogan SO, et al. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment. Chin Clin Oncol 2019; 8: 13. DOI: https://doi.org/10.21037/cco.2018.10.01
Steinke S, Zeidler C, Riepe C, Bruland P, Soto-Rey I, Storck M, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol 2018; 79: 457–463. DOI: https://doi.org/10.1016/j.jaad.2018.04.044
Ottevanger R, van Beugen S, Evers AWM, Willemze R, Vermeer MH, Quint KD. Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator. JAAD Int 2022; 9: 57–64. DOI: https://doi.org/10.1016/j.jdin.2022.07.007
Roggo A, Wüest Y, Dummer R, Ramelyte E. Pruritus is an indicator for quality of life in cutaneous T-cell lymphoma. J Dermatol 2025; 52: 1404–1410. DOI: https://doi.org/10.1111/1346-8138.17847
Halioua B, Charles B, Taieb C, Richard MA. Dispositional optimism and resilience in patients with psoriasis in France: A cross‐sectional study. Acad Dermatol Venereol 2023; 37: E1468–E1470. DOI: https://doi.org/10.1111/jdv.19367
Halioua B, Patras de Campaigno C, Merhand S, Charles B, Bru MF, Legrand C, et al. Resilience of patients with skin diseases in France: A cross‐sectional study. Acad Dermatol Venereol 2023; 37: E163–E165. DOI: https://doi.org/10.1111/jdv.18681
Additional Files
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
